Indian pharma market reflects growth of 7 percent in year 2022 - Video
|
Overview
The Indian Pharmaceutical Market (IPM) has reflected growth of 7 percent in the year 2022 with overall IPM market size at Rs 1,93,838 crore Moving Annual Turnover (MAT), as per IQVIA.
As per the report, the growth in Sales Value was recorded at 7% (MAT), and Chronic TAs growth (9% MAT) outperformed Acute TAs growth (5% MAT) in 2022.
The relative performance of the Indian Pharma companies grew faster at 7% compared to MNCs which grew at 4% in 2022. Further, the number of new launches have increased by 2% to 3032 in 2022 as compared to 2021.
For more details, check out the link given below:
Indian Pharma Firms Grew Faster At 7 Percent Compared To 4 Percent Of MNCs In 2022: IQVIA
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
